195 related articles for article (PubMed ID: 33840010)
41. Defining Oligometastatic Bladder Cancer: A Systematic Review.
Bamias A; Stenzl A; Zagouri F; Andrikopoulou A; Hoskin P
Eur Urol Open Sci; 2023 Sep; 55():28-37. PubMed ID: 37662704
[TBL] [Abstract][Full Text] [Related]
42. Oligometastatic breast cancer: A mini review.
Rastogi S; Gulia S; Bajpai J; Ghosh J; Gupta S
Indian J Med Paediatr Oncol; 2014 Jul; 35(3):203-6. PubMed ID: 25336790
[TBL] [Abstract][Full Text] [Related]
43. Pattern and Management of Recurrence of Mid-Low Rectal Cancer After Neoadjuvant Intensity-Modulated Radiotherapy: Single-Center Results of 687 Cases.
Wu AW; Cai Y; Li YH; Wang L; Li ZW; Sun YS; Ji JF
Clin Colorectal Cancer; 2018 Jun; 17(2):e307-e313. PubMed ID: 29525524
[TBL] [Abstract][Full Text] [Related]
44. Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer.
Yano T; Okamoto T; Haro A; Fukuyama S; Yoshida T; Kohno M; Maehara Y
Lung Cancer; 2013 Dec; 82(3):431-5. PubMed ID: 24113550
[TBL] [Abstract][Full Text] [Related]
45. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
46. Intent of therapy in metastatic breast cancer with isolated ipsilateral supraclavicular lymph node spread--a therapeutic dilemma.
Deo SV; Purkayastha J; Shukla NK; Raina V; Asthana S; Das DK; Rath GK
J Assoc Physicians India; 2003 Mar; 51():272-5. PubMed ID: 12839350
[TBL] [Abstract][Full Text] [Related]
47. Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution.
Yegya-Raman N; Aisner J; Kim S; Sayan M; Li D; Langenfeld J; Patel M; Malhotra J; Jabbour SK
Adv Radiat Oncol; 2019; 4(3):541-550. PubMed ID: 31360811
[TBL] [Abstract][Full Text] [Related]
48. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions.
Milano MT; Katz AW; Muhs AG; Philip A; Buchholz DJ; Schell MC; Okunieff P
Cancer; 2008 Feb; 112(3):650-8. PubMed ID: 18072260
[TBL] [Abstract][Full Text] [Related]
49. Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure.
Merloni F; Palleschi M; Casadei C; Romeo A; Curcio A; Casadei R; Stella F; Ercolani G; Gianni C; Sirico M; Cima S; Sarti S; Cecconetto L; Di Menna G; De Giorgi U
Ther Adv Med Oncol; 2023; 15():17588359231161412. PubMed ID: 36950272
[TBL] [Abstract][Full Text] [Related]
50. Clinical features and prognostic factors for extracranial oligometastatic breast cancer in China.
Lan B; Abudureheiyimu N; Zhang J; Wang C; Jiang S; Wang J; Ma F; Luo Y; Chen S; Xu B; Fan Y
Int J Cancer; 2020 Dec; 147(11):3199-3205. PubMed ID: 32535918
[TBL] [Abstract][Full Text] [Related]
51. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
52. Oligometastatic Breast Cancer: Is This a Curable Entity? A Contemporary Review of the Literature.
Makhlin I; Fox K
Curr Oncol Rep; 2020 Feb; 22(2):15. PubMed ID: 32025905
[TBL] [Abstract][Full Text] [Related]
53. Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy.
Huang L; Chen S; Yang WT; Shao Z
Oncotarget; 2017 Jun; 8(24):39703-39710. PubMed ID: 28055977
[TBL] [Abstract][Full Text] [Related]
54. Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study.
Ma Y; Duan F; Zhuang Y; Song C; Huang J; Xia W; Hong R; Zheng Q; Wang S; Shi Y; Xu F; Yuan Z; Bi X
J Oncol; 2022; 2022():7839041. PubMed ID: 36245976
[TBL] [Abstract][Full Text] [Related]
55. Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial.
Ladbury C; Hao C; Ruel C; Liu J; Glaser S; Amini A; Wong J; Paz I; Leong L; Morgan R; Margolin K; Shibata S; Frankel P; Somlo G; Dandapani S
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291784
[TBL] [Abstract][Full Text] [Related]
56. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
57. Liver metastases from breast cancer: long-term survival after curative resection.
Selzner M; Morse MA; Vredenburgh JJ; Meyers WC; Clavien PA
Surgery; 2000 Apr; 127(4):383-9. PubMed ID: 10776428
[TBL] [Abstract][Full Text] [Related]
58. Locoregional therapy for oligometastatic cervical cancer: a single-center retrospective study.
Gao H; Wu H; Zhang Y; Chen Z; Qi Z; Wang M; Cheng P
Int J Gynecol Cancer; 2023 Feb; 33(2):198-207. PubMed ID: 36229079
[TBL] [Abstract][Full Text] [Related]
59. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
[TBL] [Abstract][Full Text] [Related]
60. Retrospective study of efficacy and safety of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive locally advanced and oligometastatic breast cancer: An Indian experience.
Tiwari A; Gogia A; Deo S; Shukla NK; Mathur S; Sharma DN
Indian J Cancer; 2017; 54(1):343-346. PubMed ID: 29199719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
